MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327,410 | +11.7% | 32,741 | +38.8% | 0.00% | – |
| Q2 2023 | $293,224 | -8.4% | 23,590 | +3.3% | 0.00% | – |
| Q1 2023 | $320,002 | +80.5% | 22,841 | +84.3% | 0.00% | – |
| Q4 2022 | $177,315 | -74.8% | 12,391 | -55.0% | 0.00% | -100.0% |
| Q3 2022 | $703,000 | +5.9% | 27,529 | +17.8% | 0.00% | 0.0% |
| Q2 2022 | $664,000 | -8.2% | 23,378 | -0.6% | 0.00% | 0.0% |
| Q1 2022 | $723,000 | -20.2% | 23,515 | +8.8% | 0.00% | 0.0% |
| Q4 2021 | $906,000 | -23.1% | 21,611 | -10.0% | 0.00% | 0.0% |
| Q3 2021 | $1,178,000 | -70.4% | 24,003 | -74.9% | 0.00% | -75.0% |
| Q2 2021 | $3,986,000 | +11.7% | 95,517 | -4.6% | 0.00% | 0.0% |
| Q1 2021 | $3,567,000 | +21.1% | 100,074 | -4.7% | 0.00% | +33.3% |
| Q4 2020 | $2,946,000 | – | 105,027 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |